Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Harmony Wellness Clinic vs Somira Health

Harmony Wellness Clinic
Graded #308

Lower grade

vs+1.6000000000000014
Somira Health
Graded #269

Higher grade

The verdict

Somira Health takes it — 62.5/100 to 60.9/100, but only just.

Somira Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Somira Health is a self-pay telehealth platform that connects you with independent licensed providers and compounding pharmacies for GLP-1 weight loss. Harmony Wellness Clinic is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSomira Health +7
45
52
Dose & formulationEven
64
64
Clinical oversightHarmony Wellness Clinic +1
78
77
Labs & monitoringSomira Health +10
52
62
FulfillmentSomira Health +8
75
83
Contract termsHarmony Wellness Clinic +30
55
25
Harmony Wellness Clinic · left barSomira Health · right bar

The numbers

MetricHarmony Wellness ClinicSomira Health
WeighScore60.9/10062.5/100
GradeCC
Scorecard rank#308#269
Semaglutide$200/mo (starting dose, compounded)$190/mo (compounded)
Tirzepatide$250/mo (starting dose, compounded)$285/mo (compounded)
Coverage36 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Harmony Wellness Clinic

Graded #308 · C

Strengths

  • LegitScript certified with licensed APRN-CNP clinical oversight by Kristina Stout
  • Two compounded GLP-1 options: semaglutide+B12 (5 dose levels) and tirzepatide+B12 (6 dose levels)
  • Partners with four named 503A compounding pharmacies for a transparent supply chain
  • Competitive starting prices: $200/month for semaglutide and $250/month for tirzepatide
  • Telehealth services available in 36 states via the Optimantra online patient portal

Where it loses points

  • 36-state coverage — many states including some large markets not served
  • Care led by APRN-CNP, not an MD or DO; no physician name disclosed
  • Pricing scales with dose level up to $300/month (sema) and $450/month (tirz)
  • Labs not mentioned or included on any public page — baseline bloodwork protocol unknown
  • No coaching or lifestyle program disclosed beyond clinical dose management
Somira Health

Graded #269 · C

Strengths

  • Transparent flat monthly pricing that does not increase as you titrate (semaglutide $189.99/mo, tirzepatide $284.99/mo)
  • Quarterly plans lower the effective monthly cost (semaglutide $136.66/mo, tirzepatide $221.66/mo)
  • Free overnight shipping, with syringes and alcohol wipes included in every order
  • Simple, fast online intake reviewed by a licensed provider; no insurance required
  • Both weekly compounded GLP-1 options offered: semaglutide and tirzepatide

Where it loses points

  • Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • The compounding pharmacy partner is not named
  • State-availability list is not published
  • No LegitScript certification displayed
  • New, thin platform with limited public detail on the provider network, lab monitoring, or ongoing support

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard